|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Pennathur A, Gibson MK, Jobe BA and
Luketich JD: Oesophageal carcinoma. Lancet. 381:400–412. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Rustgi AK and El-Serag HB: Esophageal
carcinoma. N Engl J Med. 371:2499–2509. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sjoquist KM, Burmeister BH, Smithers BM,
Zalcberg JR, Simes RJ, Barbour A and Gebski V; Australasian
Gastro-Intestinal Trials Group: Survival after neoadjuvant
chemotherapy or chemoradiotherapy for resectable oesophageal
carcinoma: An updated meta-analysis. Lancet Oncol. 12:681–692.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Carninci P, Kasukawa T, Katayama S, Gough
J, Frith MC, Maeda N, Oyama R, Ravasi T, Lenhard B, Wells C, et al:
The transcriptional landscape of the mammalian genome. Science.
309:1559–1563. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Batista PJ and Chang HY: Long noncoding
RNAs: Cellular address codes in development and disease. Cell.
152:1298–1307. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ponting CP, Oliver PL and Reik W:
Evolution and functions of long noncoding RNAs. Cell. 136:629–641.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Berger AC, Korkut A, Kanchi RS, Hegde AM,
Lenoir W, Liu W, Liu Y, Fan H, Shen H, Ravikumar V, et al: A
comprehensive pan-cancer molecular study of gynecologic and breast
cancers. Cancer Cell. 33:690–705. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yuan JH, Yang F, Wang F, Ma Jz, Guo Yj,
Tao Qf, Liu F, Pan W, Wang Tt, Zhou Cc, et al: A long noncoding RNA
activated by TGF-β promotes the invasion-metastasis cascade in
hepatocellular carcinoma. Cancer Cell. 25:666–681. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang C, Yuan J, Hu H, Chen W, Liu M,
Zhang J, Sun S and Guo Z: Long non-coding RNA CHCHD4P4 promotes
epithelial-mesenchymal transition and inhibits cell proliferation
in calcium oxalate-induced kidney damage. Braz J Med Biol Res.
51:e65362017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yin D, Lu X, Su J, He X, De W, Yang J, Li
W, Han L and Zhang E: Long noncoding RNA AFAP1-AS1 predicts a poor
prognosis and regulates non-small cell lung cancer cell
proliferation by epigenetically repressing p21 expression. Mol
Cancer. 17:922018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Schmitt AM and Chang HY: Long noncoding
RNAs in cancer pathways. Cancer Cell. 29:452–463. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hu WL, Jin L, Xu A, Wang YF, Thorne RF,
Zhang XD and Wu M: GUARDIN is a p53-responsive long non-coding RNA
that is essential for genomic stability. Nat Cell Biol. 20:492–502.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li JK, Cheng C, Liu JY, Shi JZ, Liu SP,
Liu B, Wu DS, Fang ZY, Bao Y, Jiang MM, et al: Long noncoding RNA
MRCCAT1 promotes metastasis of clear cell renal cell carcinoma via
inhibiting NPR3 and activating p38-MAPK signaling. Mol Cancer.
16:1112017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang Y, Zheng X, Wang N, Zhao W, Zhang X,
Teng S, Zhang Y and Lu Z: Long noncoding RNA DANCR, working as a
competitive endogenous RNA, promotes ROCK1-mediated proliferation
and metastasis via decoying of miR-335-5p and miR-1972 in
osteosarcoma. Mol Cancer. 17:892018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhu H, Zheng T, Yu J, Zhou L and Wang L:
LncRNA XIST accelerates cervical cancer progression via
upregulating fus through competitively binding with miR-200a.
Biomed Pharmacother. 105:789–797. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang Z, Yang B, Zhang M, Guo W, Wu Z, Wang
Y, Jia L, Li S; Cancer Genome Atlas Research Network; Xie W and
Yang D: lncRNA epigenetic landscape analysis identifies EPIC1 as an
oncogenic lncRNA that interacts with MYC and promotes cell-cycle
progression in cancer. Cancer Cell. 33:706–720. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Mondal T, Juvvuna PK, Kirkeby A, Mitra S,
Kosalai ST, Traxler L, Hertwig F, Wernig-Zorc S, Miranda C, Deland
L, et al: Sense-Antisense lncRNA pair encoded by locus 6p223
determines neuroblastoma susceptibility via the USP36-CHD7-SOX9
regulatory axis. Cancer Cell. 33:417–434. 2018. View Article : Google Scholar
|
|
20
|
Lin A, Hu Q, Li C, Xing Z, Ma G, Wang C,
Li J, Ye Y, Yao J, Liang K, et al: The LINK-A lncRNA interacts with
PtdIns(3,4,5) P3 to hyperactivate AKT and confer resistance to AKT
inhibitors. Nat Cell Biol. 19:238–251. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Grelet S, Link LA, Howley B, Obellianne C,
Palanisamy V, Gangaraju VK, Diehl JA and Howe PH: A regulated PNUTS
mRNA to lncRNA splice switch mediates EMT and tumour progression.
Nat Cell Biol. 19:1105–1115. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Gilot D, Migault M, Bachelot L, Journé F,
Rogiers A, Donnou-Fournet E, Mogha A, Mouchet N, Pinel-Marie ML,
Mari B, et al: A non-coding function of TYRP1 mRNA promotes
melanoma growth. Nat Cell Biol. 19:1348–1357. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhu XT, Yuan JH, Zhu TT, Li YY and Cheng
XY: Long noncoding RNA glypican 3 (GPC3) antisense transcript 1
promotes hepatocellular carcinoma progression via epigenetically
activating GPC3. FEBS J. 283:3739–3754. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Tsai KW, Lo YH, Liu H, Yeh CY, Chen YZ,
Hsu CW, Chen WS and Wang JH: Linc00659, a long noncoding RNA, acts
as novel oncogene in regulating cancer cell growth in colorectal
cancer. Mol Cancer. 17:722018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhang S, Wang W, Liu G, Xie S, Li Q, Li Y
and Lin Z: Long non-coding RNA HOTTIP promotes hypoxia-induced
epithelial-mesenchymal transition of malignant glioma by regulating
the miR-101/ZEB1 axis. Biomed Pharmacother. 95:711–720. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Michelini F, Pitchiaya S, Vitelli V,
Sharma S, Gioia U, Pessina F, Cabrini M, Wang Y, Capozzo I,
Iannelli F, et al: Damage-Induced lncRNAs control the DNA damage
response through interaction with DDRNAs at individual
double-strand breaks. Nat Cell Biol. 19:1400–1411. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yuan JH, Liu XN, Wang TT, Pan W, Tao QF,
Zhou WP, Wang F and Sun SH: The MBNL3 splicing factor promotes
hepatocellular carcinoma by increasing PXN expression through the
alternative splicing of lncRNA-PXN-AS1. Nat Cell Biol. 19:820–832.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Su R, Cao S, Ma J, Liu Y, Liu X, Zheng J,
Chen J, Liu L, Cai H, Li Z, et al: Knockdown of SOX2OT inhibits the
malignant biological behaviors of glioblastoma stem cells via
up-regulating the expression of miR-194-5p and miR-122. Mol Cancer.
16:1712017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhao J, Zhang L, Zheng L, Hong Y and Zhao
L: LncRNATCF7 promotes the growth and self-renewal of glioma cells
via suppressing the miR-200c-EpCAM axis. Biomed Pharmacother.
97:203–208. 2018. View Article : Google Scholar
|
|
30
|
He L and Hannon GJ: MicroRNAs: Small RNAs
with a big role in gene regulation. Nat Rev Genet. 5:522–531. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Mohr S, Doebele C, Comoglio F, Berg T,
Beck J, Bohnenberger H, Alexe G, Corso J, Ströbel P, Wachter A, et
al: Hoxa9 and meis1 cooperatively induce addiction to syk signaling
by suppressing miR-146a in acute myeloid leukemia. Cancer Cell.
31:549–562. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Bu Y, Yoshida A, Chitnis N, Altman BJ,
Tameire F, Oran A, Gennaro V, Armeson KE, McMahon SB, Wertheim GB,
et al: A PERK-miR-211 axis suppresses circadian regulators and
protein synthesis to promote cancer cell survival. Nat Cell Biol.
20:104–115. 2018. View Article : Google Scholar
|
|
33
|
Yan W, Wu X, Zhou W, Fong MY, Cao M, Liu
J, Liu X, Chen CH, Fadare O, Pizzo DP, et al: Cancer-Cell-Secreted
exosomal miR-105 promotes tumour growth through the MYC-dependent
metabolic reprogramming of stromal cells. Nat Cell Biol.
20:597–609. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Chernyy V, Pustylnyak V, Kozlov V and
Gulyaeva L: Increased expression of miR-155 and miR-222 is
associated with lymph node positive status. J Cancer. 9:135–140.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Leite KR, Reis ST, Viana N, Morais DR,
Moura CM, Silva IA, Pontes J Jr, Katz B and Srougi M: Controlling
RECK miR21 promotes tumor cell invasion and is related to
biochemical recurrence in prostate cancer. J Cancer. 6:292–301.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Celia-Terrassa T, Liu DD, Choudhury A,
Hang X, Wei Y, Zamalloa J, Alfaro-Aco R, Chakrabarti R, Jiang YZ,
Koh BI, et al: Normal and cancerous mammary stem cells evade
interferon-induced constraint through the miR-199a-LCOR axis. Nat
Cell Biol. 19:711–723. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wu MZ, Cheng WC, Chen SF, Nieh S, O'Connor
C, Liu CL, Tsai WW, Wu CJ, Martin L, Lin YS, et al: MiR-25/93
mediates hypoxia-induced immunosuppression by repressing cGAS. Nat
Cell Biol. 19:1286–1296. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Yuan JH, Yang F, Chen BF, Lu Z, Huo Xs,
Zhou Wp, Wang F and Sun Sh: The histone deacetylase
4/SP1/microrna-200a regulatory network contributes to aberrant
histone acetylation in hepatocellular carcinoma. Hepatology.
54:2025–2035. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Ho CS, Noor SM and Nagoor NH: MiR-378 and
MiR-1827 regulate tumor invasion, migration and angiogenesis in
human lung adenocarcinoma by targeting RBX1 and CRKL, respectively.
J Cancer. 9:331–345. 2018. View Article : Google Scholar :
|
|
40
|
Jiang Z, Slater CM, Zhou Y, Devarajan K,
Ruth KJ, Li Y, Cai KQ, Daly M and Chen X: LincIN, a novel
NF90-binding long non-coding RNA, is overexpressed in advanced
breast tumors and involved in metastasis. Breast Cancer Res.
19:622017. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Nishihira T, Kasai M, Mori S, Watanabe T,
Kuriya Y, Suda M, Kitamura M, Hirayama K, Akaishi T and Sasaki T:
Characteristics of two cell lines (TE-1 and TE-2) derived from
human squamous cell carcinoma of the esophagus. Gan. 70:575–584.
1979.PubMed/NCBI
|
|
42
|
Barnas C, Martel-Planche G, Furukawa Y,
Hollstein M, Montesano R and Hainaut P: Inactivation of the p53
protein in cell lines derived from human esophageal cancers. Int J
Cancer. 71:79–87. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Gao J, Xue KX, Li BG, Dong HY, Wei LS,
Zhang ZH, Tian S and Xu ZG: Site-Dependence of invasiveness of
ECA109 human oesophageal carcinoma cells in nude mice. Clin Exp
Metastasis. 2:205–212. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Ye Z, Fang J, Dai S, Wang Y, Fu Z, Feng W,
Wei Q and Huang P: MicroRNA-34a induces a senescence-like change
via the down-regulation of SIRT1 and up-regulation of p53 protein
in human esophageal squamous cancer cells with a wild-type p53 gene
background. Cancer Lett. 370:216–221. 2016. View Article : Google Scholar
|
|
45
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
46
|
Li RC, Ke S, Meng FK, Lu J, Zou XJ, He ZG,
Wang WF and Fang MH: CiRS-7 promotes growth and metastasis of
esophageal squamous cell carcinoma via regulation of miR-7/HOXB13.
Cell Death Dis. 9:8382018. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Higuchi T, Todaka H, Sugiyama Y, Ono M,
Tamaki N, Hatano E, Takezaki Y, Hanazaki K, Miwa T, Lai S, et al:
Suppression of microRNA-7 (miR-7) biogenesis by nuclear factor
90-nuclear factor 45 complex (NF90-NF45) controls cell
proliferation in hepatocellular carcinoma. J Biol Chem.
291:21074–21084. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Su C, Han Y, Zhang H, Li Y, Yi L, Wang X,
Zhou S, Yu D, Song X, Xiao N, et al: CiRS-7 targeting miR-7
modulates the progression of non-small cell lung cancer in a manner
dependent on NF-κB signalling. J Cell Mol Med. 22:3097–3107. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Xu B, Yang T, Wang Z, Zhang Y, Liu S and
Shen M: CircRNA CDR1as/miR-7 signals promote tumor growth of
osteosarcoma with a potential therapeutic and diagnostic value.
Cancer Manag Res. 10:4871–4880. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Zhang E, Han L, Yin D, He X, Hong L, Si X,
Qiu M, Xu T, De W, Xu L, et al: H3K27 acetylation activated-long
non-coding RNA CCAT1 affects cell proliferation and migration by
regulating SPRY4 and HOXB13 expression in esophageal squamous cell
carcinoma. Nucleic Acids Res. 45:3086–3101. 2017. View Article : Google Scholar :
|
|
51
|
Gao YB, Chen ZL, Li JG, Hu XD, Shi XJ, Sun
ZM, Zhang F, Zhao ZR, Li ZT, Liu ZY, et al: Genetic landscape of
esophageal squamous cell carcinoma. Nat Genet. 46:1097–1102. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Li CQ, Huang GW, Wu ZY, Xu YJ, Li XC, Xue
YJ, Zhu Y, Zhao JM, Li M, Zhang J, et al: Integrative analyses of
transcriptome sequencing identify novel functional lncRNAs in
esophageal squamous cell carcinoma. Oncogenesis. 6:e2972017.
View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Lin C, Zhang S, Wang Y, Wang Y, Nice E,
Guo C, Zhang E, Yu L, Li M, Liu C, et al: Functional role of a
novel long noncoding RNA TTN-AS1 in esophageal squamous cell
carcinoma progression and metastasis. Clin Cancer Res. 24:486–498.
2018. View Article : Google Scholar
|
|
54
|
Li Y, Li J, Luo M, Zhou C, Shi X, Yang W,
Lu Z, Chen Z, Sun N and He J: Novel long noncoding RNA NMR promotes
tumor progression via NSUN2 and BPTF in esophageal squamous cell
carcinoma. Cancer Lett. 430:57–66. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Kang M, Ren M, Li Y, Fu Y, Deng M and Li
C: Exosome-mediated transfer of lncRNA PART1 induces gefitinib
resistance in esophageal squamous cell carcinoma via functioning as
a competing endogenous RNA. J Exp Clin Cancer Res. 37:1712018.
View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Wu Y, Hu L, Liang Y, Li J, Wang K, Chen X,
Meng H, Guan X, Yang K and Bai Y: Up-Regulation of lncRNA CASC9
promotes esophageal squamous cell carcinoma growth by negatively
regulating PDCD4 expression through EZH2. Mol Cancer. 16:1502017.
View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Lin C, Wang Y, Wang Y, Zhang S, Yu L, Guo
C and Xu H: Transcriptional and posttranscriptional regulation of
HOXA13 by lncRNA HOTTIP facilitates tumorigenesis and metastasis in
esophageal squamous carcinoma cells. Oncogene. 36:5392–5406. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Yoon JH, You BH, Park CH, Kim YJ, Nam JW
and Lee SK: The long noncoding RNA LUCAT1 promotes tumorigenesis by
controlling ubiquitination and stability of DNA methyltransferase 1
in esophageal squamous cell carcinoma. Cancer Lett. 417:47–57.
2018. View Article : Google Scholar
|
|
59
|
Yang X, Song JH, Cheng Y, Wu W, Bhagat T,
Yu Y, Abraham JM, Ibrahim S, Ravich W, Roland BC, et al: Long
non-coding RNA HNF1A-AS1 regulates proliferation and migration in
oesophageal adenocarcinoma cells. Gut. 63:881–890. 2014. View Article : Google Scholar
|
|
60
|
Luo HL, Huang MD, Guo JN, Fan RH, Xia XT,
He JD and Chen XF: AFAP1-AS1 is upregulated and promotes esophageal
squamous cell carcinoma cell proliferation and inhibits cell
apoptosis. Cancer Med. 5:2879–2885. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Li W, Zheng J, Deng J, You Y, Wu H, Li N,
Lu J and Zhou Y: Increased levels of the long intergenic
non-protein coding RNAPOU3F3 promote DNA methylation in esophageal
squamous cell carcinoma cells. Gastroenterology. 146:1714–1726
e1715. 2014. View Article : Google Scholar
|
|
62
|
Iyer MK, Niknafs YS, Malik R, Singhal U,
Sahu A, Hosono Y, Barrette TR, Prensner JR, Evans JR, Zhao S, et
al: The landscape of long noncoding RNAs in the human
transcriptome. Nat Genet. 47:199–208. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Zhuang J, Shen L, Yang L, Huang X, Lu Q,
Cui Y, Zheng X, Zhao X, Zhang D, Huang R, et al: TGFβ1 promotes
gemcitabine resistance through regulating the
LncRNA-LET/NF90/miR-145 signaling axis in bladder cancer.
Theranostics. 7:3053–3067. 2017. View Article : Google Scholar :
|
|
64
|
Zhang W, Xiong Z, Wei T, Li Q, Tan Y, Ling
L and Feng X: Nuclear factor 90 promotes angiogenesis by regulating
HIF-1α/VEGF-A expression through the PI3K/akt signaling pathway in
human cervical cancer. Cell Death Dis. 9:2762018. View Article : Google Scholar
|
|
65
|
Liu J, Zhan Y, Wang J, Wang J, Guo J and
Kong D: Long noncoding RNA LINC01578 drives colon cancer metastasis
through a positive feedback loop with the NF-κB/YY1 axis. Mol
Oncol. 14:3211–3233. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Song D, Huang H, Wang J, Zhao Y, Hu X, He
F, Yu L and Wu J: NF90 regulates PARP1 mRNA stability in
hepatocellular carcinoma. Biochem Biophys Res Commun. 488:211–217.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Barbier J, Chen X, Sanchez G, Cai M,
Helsmoortel M, Higuchi T, Giraud P, Contreras X, Yuan G, Feng Z, et
al: An NF90/NF110-mediated feedback amplification loop regulates
dicer expression and controls ovarian carcinoma progression. Cell
Res. 28:556–571. 2018. View Article : Google Scholar : PubMed/NCBI
|
